AcquisitionsJul 27, 2026, 04:12 PM
FOXO Subsidiary Acquires 4 Blood Centers for $3.5M Plus Earn-Out
AI Summary
FOXO Technologies Inc.'s subsidiary, Vector BioSource, Inc., entered into an asset purchase agreement to acquire four U.S.-based blood collection centers from Grifols Bio Supplies, Inc. The deal involves an initial cash consideration of $3,500,000, with a potential earn-out of up to $1,000,000 based on EBITDA performance. The acquisition is subject to various closing conditions, including obtaining new regulatory licenses, and is expected to close in Q3 or Q4 2026.
Key Highlights
- Vector BioSource, a FOXO subsidiary, acquired four U.S.-based blood collection centers.
- Initial cash consideration for the acquisition is $3,500,000.
- A contingent earn-out payment of up to $1,000,000 is also included.
- Earn-out is payable if acquired business generates $1,500,000 EBITDA in 2026, 2027, or 2028.
- Closing is subject to customary conditions, including new FDA license and CLIA certification.
- The company anticipates closing the acquisition in the third or fourth quarter of 2026.
Price Impact
More from FOXO